ALPHA TEKNOVA INC

Alpha Teknova shares plunge 20% as the firm gears up for a Q3 2026 earnings release and a new 8‑million‑share offering—will the fresh capital boost reverse the trend?

Alpha Teknova’s latest stock plunge, underwritten offering, and Q3 revenue growth reveal a biotech’s risk‑reward trade‑off and capital strategy.

Alpha Teknova shares jump 8.7% to $7.39, beating market trends and nearing its 200‑day moving average—explore why biotech stock could be rebounding now.